Recon: WHO review of India's Covaxin underway; Novartis mulls spinoff of generic unit Sandoz

Recon

ReconMichael Mezher

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy